Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 263 - Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
Patents for C07D 263 - Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings (20,978)
11/2005
11/30/2005EP1599452A1 3-(2-phenyl-oxazol-4-yl methoxy) cyclohexylmethoxy acetic acid derivatives and related compounds used as ppar modulators for treating type 2 diabetes and arteriosclerosis
11/30/2005EP1599449A2 Carbamic acid compounds comprising a bicyclic heteroaryl group as hdac inhibitors
11/30/2005EP1599433A1 Method for producing the enantiomeric forms of cis 1,3-cyclohexanediol derivatives
11/30/2005EP1599203A1 1,3-substituted cycloalkyl derivatives containing acidic, mainly heterocyclic groups, corresponding production method and use of said derivatives as medicaments
11/30/2005EP1091943B1 Non-peptidyl inhibitors of vla-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases
11/30/2005CN1703407A Inhibitors of fatty acid amide hydrolase
11/30/2005CN1703406A Chirale oxazole-arylpropionic acid derivatives and their use as PPAR agonists
11/30/2005CN1703395A Aryl and heteroaryl compounds and methods to modulate coagulation
11/30/2005CN1702070A N-benzyl acryloyl substituted tyrosine derivatives as hPPAR alpha and hPPAR gamma agonist
11/30/2005CN1702069A Alpha-piperazine substituted phenyl-propionic acid derivatives as hPPAR alpha and hPPAR gamma agonist
11/30/2005CN1702068A Alkanoyl substituted tyrosine derivatives as hPPAR alpha and hPPAR gamma agonist
11/30/2005CN1229364C Intermediates and methods useful in the semisynthesis of paclitaxel and analogs
11/30/2005CN1229336C Photoactive compound used as intermediate for preparing photoactive 2-imidazoline-5-ketone or 2-imdazoline-5-thio-ketone derivative
11/29/2005US6969727 Obesity; osteoporosis
11/29/2005US6969726 can be used as anti-proliferative agents and/or anti-infective agents that can be used without limitation as anti-inflammatory agents
11/29/2005US6969725 Oxazole derivatives
11/29/2005US6969715 6-membered heterocyclic compounds useful for selective inhibition of the coagulation cascade
11/29/2005US6969711 Cyclic diamine compounds and medicine containing the same
11/24/2005WO2005110990A1 Hydroxy-substituted benzo-condensed heterocycles for use as beta agonists in the treatment of respiratory diseases
11/24/2005US20050261503 Heteroaromatic glucokinase activators
11/24/2005US20050261499 Process for preparing (r)-aryloxypropionic acid ester derivatives
11/24/2005US20050261365 Transthyretin stabilization
11/24/2005US20050261305 Cyclic protein tyrosine kinase inhibitors
11/24/2005US20050260144 Benzoxazole and benzodiazole uv-a sunscreens
11/24/2005US20050260126 Diagnostic probes and remedies for diseases with accumulation of prion protein, and stains for prion protein
11/24/2005CA2565243A1 Hydroxy-substituted benzo-condensed heterocycles for use as beta agonists in the treatment of respiratory diseases
11/23/2005EP1598340A1 1-(4-piperidinyl)-1,3-dihydro-2h-benzoxazole-2-one derivatives and related compounds as nociceptin analogs and orl1 ligands for the treatment of pain
11/23/2005EP1598339A1 1-(4-amino-cyclohexyl)-1,3-dihydro-2h-benzimidazole-2-one derivatives and related compounds as nociceptin analogs and orl1 ligands for the treatment of pain
11/23/2005EP1598338A1 1-(4-piperidinyl)-1,3-dihydro-2h-indole-2-one derivatives and related compounds as nociceptin analogs and orl1 ligands for the treatment of pain
11/23/2005EP1597322A2 Metal complexes as light-absorbing compounds in the information layer of optical data carriers
11/23/2005EP1597248A2 Sulfonamide derivatives as ppar modulators
11/23/2005EP1597246A2 Inhibitors of hepatitis c virus rna-dependent rna polymerase, and compositions and treatments using the same
11/23/2005EP1597243A1 Heterocyclic compounds useful as nurr-1 activators
11/23/2005EP1597236A1 Growth promotion method
11/23/2005CN1699349A Method and reagents for N-alkylating ureides
11/23/2005CN1228337C Carbamic acid derivatives and their use as metabotropic glutamate receptor ligands
11/23/2005CN1228327C Carboxylic acid derivatives and drugs containing the same
11/22/2005US6967251 Reagents for labeling biomolecules having aldehyde or ketone moieties
11/22/2005US6967214 Inhibitors of IMPDH enzyme
11/22/2005CA2162122C Use of glycine-n,n-diacetic acid derivatives as biodegradable complexing agents for alkaline earth and heavy metal ions, and method of preparing them
11/17/2005WO2005108380A2 Process employing controlled crystallization in forming crystals of a pharmaceutical
11/17/2005WO2005107762A2 Certain chemical entities, compositions, and methods
11/17/2005WO2005107464A2 Compounds and compositions as cathepsin s inhibitors
11/17/2005US20050256314 Process employing controlled crystallization in forming crystals of a pharmaceutical
11/17/2005US20050256313 Co-surfactants based on aldehydes
11/17/2005US20050256191 Nitroaniline-based alkylating agents and their use as prodrugs
11/17/2005US20050256116 Novel biaromatic compounds which activate PPARy type receptors and cosmetic/pharmaceutical compositions comprised thereof
11/17/2005US20050255055 Protecting human and animal hair or skin from UV radiation by applying a 4,4-disubstituted -1,3-butadienylamine; 4,4-substituents may be the same or different and are cyano, ester, sec. or tert. amide, ketone and/or sulfone, e.g., 4,4-bis(hexyloxycarbonyl)-N,N-diethyl-1,3-butadienylamine
11/17/2005CA2565695A1 Certain chemical entities and compositions for use in the treatment of a cellular proliferative disease or disorder
11/16/2005EP1594865A2 Antibacterial agents
11/16/2005EP1594852A1 Oxazolidinone derivatives as antimicrobials
11/16/2005EP1594847A2 Substituted azole derivatives as therapeutic agents
11/16/2005EP1594508A2 Novel bicyclic compounds and compositions
11/16/2005EP1594494A1 Oxazolidinone derivatives n-substituted by a bicyclic ring, for use as antibacterial agents
11/16/2005EP1326850B1 A process for the preparation of bis-benzazolyl compounds
11/16/2005CN1227250C Process for preparing azacycloalkanoyl aminothiazoles
11/16/2005CN1227244C Herbicidal benzoyl derivatives
11/16/2005CN1227239C Method for preparing substituted oxazole
11/16/2005CN1227231C Ether and amide compounds as medicine for treating glycuresis and preparing process thereof
11/15/2005CA2167183C Process for making hiv protease inhibitors
11/10/2005WO2005105764A1 Butanoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic applications threreof
11/10/2005WO2005082871A3 Guanidine compounds, and use thereof as binding partners for 5-ht5 receptors
11/10/2005US20050250825 peroxisome proliferator activated receptor modulators; diabetes mellitus; side effects reduction; 2-Methyl-2-{4-[2-(5-methyl-2-phenyloxazol-4-yl)ethoxy]phenoxy}propionic acid; Syndrome X, Type II diabetes, hyperglycemia, hyperlipidemia, obesity, coagaulopathy, hypertension, atherosclerosis
11/10/2005US20050250824 Carboxylic acid derivative and a pharmaceutical composition containing the derivative as active ingredient
11/10/2005US20050250822 Substituted benzanilide compound and noxious organism controlling agent
11/10/2005US20050250707 HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
11/10/2005US20050250152 fluorescent derivatization reagents that label substances containing aldehydes, ketones, and similar functional groups, and their use in labeling glycoproteins and glycopeptides, nucleic acids and lipopolysaccharides, and other biomolecules
11/10/2005CA2565184A1 Butanoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic applications threreof
11/09/2005EP1593675A1 Hetero-polycyclic compounds, and coloring matters, pigments, dyes, color-changing material compositions, and color-changing films, made by using the compounds
11/09/2005EP1593674A1 Optically active bisoxazoline compounds, process for production of the same and use thereof
11/09/2005EP1592676A1 Process for the recovery of oxazole
11/09/2005EP1592670A1 Mercaptoimidazoles as ccr2 receptor antagonists
11/09/2005EP1216223B1 Novel dicarboxylic acid derivatives with pharmaceutical properties
11/09/2005EP1212296B1 Phosphate mimics and methods of treatment using phosphatase inhibitors
11/09/2005EP0844874B1 METHODS AND COMPOSITIONS USEFUL FOR INHIBITION OF ALPHA v BETA 5 MEDIATED ANGIOGENESIS
11/09/2005CN1694873A Vanilloid receptor ligands and their use in treatments
11/09/2005CN1694704A Use of (1H-benzimidazole-2-yl)-(piperazineyl)- ketaderavitive and correlative compound used as histamine H4 receptor antagonist for the treatment of allergy and asthma
11/09/2005CN1226294C Fused heteroaromatic glucokinase activators
11/08/2005US6962999 Using a nickel or palladium catalyzed coupling in which the catalyst has at least one phosphine or phosphite ligand
11/08/2005CA2155104C Heterocyclic-substituted alkyl amide acat inhibitors
11/03/2005WO2005103020A1 1,3,5-substituted phenyl derivative compounds useful as beta-secretase inhibitors for the treatment of alzheimer's disease
11/03/2005WO2005103017A1 Method for increasing specific surface area of slightly soluble drug
11/03/2005WO2005103012A1 Hydrazino-substituted heterocyclic nitrile compounds and use thereof
11/03/2005WO2004099165A3 Heterocyclic compounds and hydro isomers thereof
11/03/2005US20050245584 Peroxisome proliferator activated receptor agonists
11/03/2005US20050245583 Pesticides for crops; agriculture, horticulture
11/03/2005US20050245542 Pyridazine, pyrimidine and pyrazine ethyne compounds
11/03/2005US20050245500 Beta-ketoamide compounds with MCH antagonistic activity
11/03/2005US20050245432 N-methyl amino acids
11/03/2005US20050245408 Sustained release; controlled chemical cascade; storage stability
11/03/2005US20050244718 Polymerizable, luminescent compounds and mixtures, luminescent polymer materials and their use
11/03/2005CA2563615A1 1,3,5-substituted phenyl derivative compounds useful as beta-secretase inhibitors for the treatment of alzheimer's disease
11/03/2005CA2563330A1 A process for the preparation of 2,2-disubstituted pyrroles
11/02/2005EP1590340A1 Inhibitors of histone deacetylase
11/02/2005EP1590321A2 Aryl alkyl carbamate derivatives production and use thereof in therapy
11/02/2005EP1049686B1 Intermediates and methods useful in the semisynthesis of paclitaxel and analogs
11/02/2005CN1692108A Pesticidal heterocycles
11/02/2005CN1225462C New piperazine and piperidine compounds
11/01/2005US6960688 Use of compounds for the elevation of pyruvate dehydrogenase activity
11/01/2005US6960665 Process for arylating or vinylating or alkynating a nucleophilic compound
1 ... 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 ... 210